The impact of the COVID-19 lockdown on glycaemic control and other metabolic parameters
in patients with type 2 diabetes is still evolving. Aim: This systematic review and meta …

Eighteen months into the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)(coronavirus disease 2019 [COVID-19]) pandemic, epidemiologic studies indicate that …

Background Diabetes is a cardiometabolic comorbidity that may predispose COVID‐19
patients to worse clinical outcomes. This study sought to determine the prevalence of …

Objectives: Pre-existing or new diabetes confers an adverse prognosis in people with Covid-
19. We reviewed the clinical literature on clinical outcomes in metformin-treated subjects …

Mucormycosis—A serious threat in the COVID-19 pandemic? - Journal of Infection Skip to
Main Content Skip to Main Menu Advertisement Journal of Infection Submit Log in Register …

Diabetes is prevailing in pandemic proportions, as nearly half a billion population is affected
by diabetes worldwide. The expenditure on diabetes healthcare is estimated to grow to $845 …

The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global health crisis affecting …

Recent evidence suggests a role for Diabetes Mellitus in adverse outcomes from COVID‐19
infection; yet the underlying mechanisms are not clear. Moreover, attention has turned to …

Background In the past few decades, diabetes‐related cardiovascular mortality has been
steadily declining. However, the impact of the COVID19 pandemic on this trend has not …

Background: Due to the unpredictable nature of COVID-19, there is a need to identify
patients at high risk of severe course of the disease and a higher mortality rate. Objective …